Pregled bibliografske jedinice broj: 614318
Effect of American Ginseng (Panax Quinquefolius L.) on Glycemic Control in Type 2 Diabetes
Effect of American Ginseng (Panax Quinquefolius L.) on Glycemic Control in Type 2 Diabetes // Collegium antropologicum, 36 (2012), 4; 1435-1440 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 614318 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effect of American Ginseng (Panax Quinquefolius L.) on Glycemic Control in Type 2 Diabetes
Autori
Mucalo, Iva ; Rahelić, Dario ; Jovanovski, Elena ; Božikov, Velimir ; Romić, Željko ; Vuksan, Vladimir
Izvornik
Collegium antropologicum (0350-6134) 36
(2012), 4;
1435-1440
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
glycemic control; diabetes; ginseng; American ginseng
Sažetak
Since diabetes tends to progressively worsen over time, glycemic control often deteriorates in spite of taking regular therapy. Therefore, numerous research studies are by and large focused on finding more efficient therapy, both new medicines for treating type 2 diabetes mellitus, as well as supplements that could serve as an addition to conventional treatment modalities. A variety of herbal preparations have been shown to have modest short-term beneficial effects on glycemia, but of these, the best studied is American ginseng (AG). AG has been shown to be effective in improving glycemic control in type 2 diabetes through increasing post-prandial insulin levels and decreasing postprandial glycemic response. However, high variability in ginsenosides may result in just as high variability in antidiabetic efficacy of over-the-counter ginseng products. Therefore, the availability of standardized extracts of AG could assist greatly in advancing our knowledge on the role of this traditionally used herb and result in a wider application of ginseng product in diabetes management. The aim of this review is to outline the efficacy and safety of AG preparations on glycemic control in patients with type 2 diabetes mellitus as well as to increase awareness of the evidence supporting the use of these therapies in diabetes care.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Profili:
Velimir Božikov
(autor)
Vladimir Vuksan
(autor)
Iva Mucalo
(autor)
Željko Romić
(autor)
Dario Rahelić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE